The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism

Area of Science:

• Nephrology
• Endocrinology
• Public Health

Background:

• Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (CKD).
• SHPT significantly elevates morbidity and mortality risks in CKD patients, particularly cardiovascular events.
• Clinical management of SHPT is often hindered by suboptimal clinician practices and patient non-adherence to treatment.

Purpose of the Study:

• To identify and analyze the primary difficulties encountered in managing SHPT.
• To explore the perspectives of both healthcare providers and CKD patients regarding SHPT treatment challenges.
• To highlight specific areas of difficulty including dialysis, nutritional habits, and medical therapy.

Main Methods:

• This study is a review of existing literature and clinical practice guidelines.
• It synthesizes information on the challenges in SHPT treatment from both clinician and patient viewpoints.
• Focus is placed on factors influencing treatment efficacy and adherence.

Main Results:

• Clinician-related challenges include diagnostic and therapeutic conduct.
• Patient-related challenges encompass non-compliance with prescribed therapies.
• Difficulties are exacerbated by factors associated with dialysis, nutritional status, and medication regimens.

Conclusions:

• Effective management of SHPT in CKD requires addressing both clinical practice and patient adherence issues.
• Improving SHPT treatment necessitates a comprehensive approach considering dialysis, nutrition, and medical therapy.
• Further strategies are needed to overcome the identified barriers for better patient outcomes.